|

Lapine T-Lymphocyte Immune Globulin Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Anti-thymocyte Globulin Rabbit, Grafalon, Rabbit ATG, Rabbit Anti-Human Thymocyte Globulin (RATG), Rabbit Anti-Thymocyte Globulin +3 more

Pipeline

Phase 1/2: 1

Top Sponsors

  • Fred Hutchinson Cancer Center1

Indications

  • Non-Malignant Neoplasm1
  • Cancer1

Seattle, Washington1 trial

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutch/University of Washington Cancer Consortium

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.